Sharon Pennington
Pediatric Hematology-Oncology · Flowood, MSNPI 1801015136
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (56.5%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Global Blood Therapeutics, Inc. at 34.2% of the total.
Across 50 payments — averaging $340.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Global Blood Therapeutics, Inc.$6K
- Octapharma USA, Inc.$5K
- AstraZeneca$3K
- Agios Pharmaceuticals, Inc.$2K
- Genentech USA, Inc.$525
- Novo Nordisk$241
- plus $324 from 5 others
Across 198 payments — averaging $2068.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$245K
- Genentech, Inc.$70K
- Agios Pharmaceuticals, Inc.$47K
- Global Blood Therapeutics, Inc.$45K
- CSL Behring$2K
- Novartis$312
What the payments were for
- Consulting fees$2,77516%
- Speaking & faculty fees$2,50015%
- Travel & lodging$9,61756%
- Food & beverage$2,14213%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Global Blood Therapeutics, Inc. | 5 | $5,820 |
| Octapharma USA, Inc. | 17 | $5,389 |
| AstraZeneca | 1 | $2,775 |
| Agios Pharmaceuticals, Inc. | 9 | $1,961 |
| Genentech USA, Inc. | 6 | $525 |
| Novo Nordisk | 2 | $241 |
| Pfizer | 6 | $193 |
| Shire North American Group Inc | 1 | $70 |
| Sanofi | 1 | $33 |
| CSL Behring | 1 | $15 |
| Emmaus Medical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few pediatric hematology-oncology providers in Mississippito place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 92 | $1,029 |
| Promethazine Hcl | 65 | $659 |
| Morphine Sulfate ErMorphine Sulfate | 22 | $466 |
| Fentanyl | 13 | $440 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $387 |
| Gabapentin | 13 | $207 |
| Cyclobenzaprine Hcl | 23 | $193 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $182 |
| Ondansetron OdtOndansetron | 11 | $128 |
| Hydroxyzine Pamoate | 11 | $77 |
| Tizanidine Hcl | 25 | $76 |
| Ibuprofen | 12 | $29 |
Paid to pharmacies, not to this prescriber.
Other pediatric hematology-oncology in Flowood
- Spencer SullivanMadison$92K
- Betty HerringtonJackson$23K
- Laura ArnoldJackson$2K
- Anderson CollierJackson$2K
- Catherine GordonJackson$1K
- Amanda StrobelJackson$731
- Melissa McNaullJackson$388
- Rathi IyerJackson$61
- Mauricio Rendon BernotPicayune$47
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.